Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00536133
Other study ID # MDPG05/01
Secondary ID
Status Completed
Phase Phase 3
First received September 25, 2007
Last updated August 3, 2009
Start date April 2006
Est. completion date July 2008

Study information

Verified date August 2009
Source Jawaharlal Nehru Medical College
Contact n/a
Is FDA regulated No
Health authority India: Indian Council of Medical Research
Study type Interventional

Clinical Trial Summary

Acute respiratory infections (ARIs) are the most frequent illnesses globally. Despite advances in the recognition and management ARIs, these account for over 20% of all child deaths globally.Trace mineral deficiencies have long been implicated in causation and consequences of many diseases. The importance of adequate zinc intake in human health is well documented and zinc deficiency is a large public health problem, especially among children in developing countries.Various studies suggest that zinc-deficient populations are at increased risk of developing diarrhoeal diseases, respiratory tract infections and growth retardation.Among the individual interventions zinc supplementation with universal coverage ranks 5th in preventing under five mortality in India, preceded only in order by breast feeding; complementary feeding; clean delivery; Hib vaccination; and clean water, sanitation and hygiene.Numerous studies have examined the association between child mortality and zinc deficiency. A number of randomized controlled trials evaluating effect of zinc supplementation have found the intervention to be beneficial in reducing ARI and diarrhoeal mortality and morbidity but few studies have found beneficial effect in diarrhea and no or even contrasting effects on morbidity pattern of acute respiratory infections. Whereas role of zinc in diarrhea is now a well established and specific guidelines and recommendations have been given for zinc supplementation in diarrhea, role of zinc in acute respiratory infections is controversial. The contrasting effect of zinc on diarrhoea and acute lower respiratory infection as reported in several studies is a public health concern, because zinc supplementation is carried out in many nutrition rehabilitation units. Further in many of randomized control trials supplement syrups also contained other vitamins, including vitamin A, known to have effect on respiratory morbidity. Most of the trials evaluating effect of zinc on respiratory morbidity and mortality are community based and children with well known causes of recurrent acute lower respiratory infections have not been excluded from the study pool.

Hence the current study was planned to bridge this gap of information and attempts to detect the role of zinc using "zinc only preparations" in reducing respiratory morbidity in children aged 6 to 59 months with recurrent acute lower respiratory infections.


Recruitment information / eligibility

Status Completed
Enrollment 208
Est. completion date July 2008
Est. primary completion date May 2008
Accepts healthy volunteers No
Gender Both
Age group 6 Months to 59 Months
Eligibility Inclusion Criteria:

- Children aged 6 to 59 months with documented recurrent acute lower respiratory infection i.e., more than two episodes of ALRI in one year or more than three episodes in any time frame.

Exclusion Criteria:

- Children with congenital heart diseases

- Children with congenital anomalies which can cause recurrent chest infection

- Children with Tuberculosis

- Children with bronchial asthma or hyperactive airway disease

- Children with WZS < -2 of HZS < -2 as per WHO standards

- Children with any diarrhoeal episode in past 3 months

- Children having receive any zinc supplementation in past 3 months

- Children who did not turn up on follow up and could not be contacted were excluded from the study.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Drug:
Zinc
5 ml of syrup containing zinc gluconate equivalent to 10 mg of elemental zinc per day for 60 days
Other:
placebo
5 ml of syrup, identical in taste, color and consistency to the syrup given to zinc group, but containing no zinc

Locations

Country Name City State
India Jawaharlal Nehru Medical College, Aligarh Muslim University Aligarh Uttar Pradesh

Sponsors (2)

Lead Sponsor Collaborator
Jawaharlal Nehru Medical College Indian Council of Medical Research

Country where clinical trial is conducted

India, 

References & Publications (7)

Bhandari N, Bahl R, Taneja S, Strand T, Mølbak K, Ulvik RJ, Sommerfelt H, Bhan MK. Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum. BMJ. 2002 Jun 8;324(7350):1358. — View Citation

Bhatnagar S, Natchu UC. Zinc in child health and disease. Indian J Pediatr. 2004 Nov;71(11):991-5. Review. — View Citation

Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003 Jun 28;361(9376):2226-34. Review. — View Citation

Caufield L, Black R. Zinc deficiency. In: Ezzati M, Lopez AD, Rodgers A, Murray C, eds. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004:257-259

Rahman MM, Vermund SH, Wahed MA, Fuchs GJ, Baqui AH, Alvarez JO. Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial. BMJ. 2001 Aug 11;323(7308):314-8. — View Citation

Ruel MT, Rivera JA, Santizo MC, Lönnerdal B, Brown KH. Impact of zinc supplementation on morbidity from diarrhea and respiratory infections among rural Guatemalan children. Pediatrics. 1997 Jun;99(6):808-13. — View Citation

Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics. 1998 Jul;102(1 Pt 1):1-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary change in mean serum zinc level; Number of episodes of ALRI per child ALRI free days per child per year; six months No
Secondary Diarrhoeal episodes per child; morbidity free days per child; mean hospitalization days; change in Weight for age and height for age z scores six months No
See also
  Status Clinical Trial Phase
Completed NCT01731834 - Pain and Stress Assessment in Children Early Phase 1
Completed NCT00377403 - Treatment of Acute Sinusitis Phase 4
Completed NCT02003651 - Echinacea and Acute Respiratory Illness N/A
Completed NCT01116076 - DECISION+, a Training Program to Improve Optimal Drug Prescription Phase 1
Completed NCT01918579 - C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting N/A
Completed NCT02512614 - Evaluation of Novel Antimicrobial Hand Towels Phase 2/Phase 3
Completed NCT02378090 - A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico N/A
Completed NCT00851487 - Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months N/A